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Sortase A (SrtA) is a membrane enzyme responsible for the covalent anchoring of surface 
proteins on the cell wall of Gram-positive bacteria. Nowadays, it is considered an interesting target 
for the development of new anti-infective drugs which aim to interfere with important Gram-positive 
virulence mechanisms. Along the years, we studied the anti-staphylococcal and anti-biofilm activity 
of some natural and synthetic polyhalogenated pyrrolic compounds, called pyrrolomycins. Some of 
them were active on Gram-positive pathogens at a μg/mL range of concentration (1.5–0.045 μg/mL) 
and showed a biofilm inhibition in the range of 50–80% [1–3]. 
We designed and synthesized novel pyrrolomycins, applying an efficient and easy-to-use 
microwave synthetic methodology. All compounds showed a good inhibitory activity toward SrtA, 
in accordance with the molecular modelling studies, having IC50 values ranging from 130 to 300 μM 
comparable to berberine hydrochloride. The best compound exhibits a high capability to interfere 
with biofilm formation of S. aureus with an IC50 in the nanomolar range. It is also effective in altering 
S. aureus murein hydrolase activity, responsible for degradation, turnover, and maturation of 
bacterial peptidoglycan [4]. In light of these encouraging results, herein we present our efforts in 
finding new effective agents able to inhibit biofilm formation.  
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